Terence Novak has been appointed president of commercial operations for Norwich Pharmaceuticals. Mr. Novak will provide strategic leadership for the company’s commercial business group that includes sales, marketing and customer service. He will report to chief executive officer of Norwich, Doug Drysdale.

“We are pleased to welcome Terry Novak to Norwich and look forward to his results-oriented approach to business development and customer service,” said Mr. Drysdale. “His expertise within the contract services industry complemented by his energetic commitment to customers will be a strong addition to our leadership team.”

Mr. Novak most recently served as president and chief commercial officer for Patheon, where he successfully achieved an increase in new business while also overseeing five manufacturing facilities. Mr. Novak previously held several senior leadership positions at DSM Pharmaceuticals including senior vice president commercial operations, executive vice president and chief marketing officer, and president and business unit director. He also has more than 15 years of sales and management experience with Bristol-Myers Squibb. Mr. Novak is a member of Contract Pharma’s Editorial Advisory Board.

Click here to learn more about Norwich